USPTO serial 78395637
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniele E. Bourgeois, Esq.
DANIELE E BOURGEOIS ESQ TROUTMAN SANDERS LLP600 PEACHTREE ST NE STE 5200BANK OF AMERICA PLZATLANTA, GA 30308-2216| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Traditional Chinese health-related preparations and substances for medical, dietary supplement or dietetic use, namely botanical, herbal and Chinese medicine-based health products, namely, nutritional supplements, nutritional food supplements, nutritional drink mix for use as a meal replacement; nutritional shakes for use as a meal substitute, powdered nutritional supplement drink mix; Chinese herbal preparations and substances for medical and dietary supplement use, namely botanical, herbal and Chinese medicine-based dietary supplements; herbal remedies and preparations, namely herbal dietary, herbal health products, or other herbal products for medicinal or dietary supplement or dietetic use, namely, nutritional supplements, nutritional food supplements, nutritional drink mix for use as a meal replacement; nutritional shakes for use as a meal substitute, powdered nutritional supplement drink mix; Chinese pharmaceutical preparations for use in the treatment of medical conditions or restoration of metabolic or physiological imbalances of diseased body states, namely, conditions associated with the cardiovascular system, musculoskeletal system, central nervous system, endocrine system, peripheral nervous system, genitourinary system, respiratory system, dermatology, digestive system and immune system; Chinese medicinal herbs in dry or preserved form; Chinese medicine compounds, components, fractions and extracts, namely products based on or containing Chinese medicine herbs or derived extracts, fractions, components or compounds in the dosage forms of capsules, tablets, pills, granules, powders, paste, solutions, syrups, ointments, gums, teas and patches, namely medicinal herb extracts; preserved herbal preparations, namely, herbal-based products in the forms of capsules, tablets, pills, granules, powders, paste, solutions, syrups, ointments, gums, teas and patches, namely dietary supplements, dietary food supplements, dietary supplement drinks; Chinese herb teas for medicinal purposes; dietetic foods and drinks for medicinal use; preserved herbal preparations, namely Chinese herbal supplements, dietary supplements; herbal syrups for pharmaceutical purposes for use in the treatment of health promotion or maintenance or in the treatment of medical conditions or restoration of metabolic, physiological or immunological imbalances of diseased body states, namely, conditions associated with the cardiovascular system, musculoskeletal system, central nervous system, endocrine system, peripheral nervous system, genitourinary system, respiratory system, dermatology, digestive system and immune system; dietary supplements; food for medically restricted diets and health food supplements made principally of Chinese herbs; Chinese herbal supplements; almond oil for medicinal purposes; pharmaceutical preparations for use in the treatment of medical conditions or restoration of metabolic, physiological or immunological imbalances of diseased body states, namely, conditions associated with the cardiovascular system, musculoskeletal system, central nervous system, endocrine system, peripheral nervous system, genitourinary system, respiratory system, dermatology, digestive system and immune system; and sanitary preparations for medicinal use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 20, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 24, 2006 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 24, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 3, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2006 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 19, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 17, 2005 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 17, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 14, 2005 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 10, 2005 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 10, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 9, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 29, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2005 | PAPER RECEIVED | — | |
| Oct 25, 2004 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 25, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2004 | NWAP | NEW APPLICATION ENTERED | — |